Navigation Links
Sodium transporter appears likely target for treating salt-sensitive hypertension
Date:2/26/2013

AUGUSTA, Ga. Genetics and demographics likely put you at risk for salt-sensitive hypertension, and scientists are looking for a way to protect you.

The concept is that free radicals in the kidney prompt the organ to hold onto sodium rather than eliminate excess through urination. Excess sodium, in turn, increases free radical production, said Dr. Paul O'Connor, hypertension researcher in the Section of Experimental Medicine at the Medical College of Georgia at Georgia Regents University.

Blocking the hydrogen transporter HVI best known for its role in helping immune cells produce large amounts of free radicals to kill bacteria may stop the unhealthy, vicious cycle.

"We think HVI overexpression in the kidney fuels the production of too many free radicals, which can activate the sodium transporters to hold onto more sodium, leading to hypertension and kidney damage," O'Connor said.

With the help of a New Investigator Award from the American Heart Association and a HV1 mutant rat, he plans to find out.

Sodium helps the kidneys regulate fluid volume and blood pressure. However being older, black and obese are risk factors for holding onto too much sodium. Nearly 40 percent of blacks and 30 percent of whites with healthy blood pressure have a tendency to hold onto salt and so-called salt sensitivity occurs in nearly 75 percent of blacks and more than half of whites with hypertension.

O'Connor has found HVI in the nephrons of the kidneys where decisions are made about how much sodium to retain. And, when looking at sodium transport inside renal tubule cells, he found a drug he was using inhibited free radical production and started putting the pieces together.

O'Connor and his collaborators developed the HV1 mutant of the Dahl salt-sensitive rat, which becomes hypertensive on a high-salt diet, to test the emerging hypothesis.

"We think if HV1 is not present, you will have reduced salt sensitivity, reduced oxidative stress and reduced renal injury when you feed these animals a high-salt diet," O'Connor said.

If he's correct, targeted treatment for salt-sensitive hypertension may emerge. "We think it might be an interesting target to help inhibit oxidative-stress related cardiovascular disease," O'Connor said.

Although free radicals are a known contributor to cardiovascular disease, antioxidants haven't proven effective therapy, said O'Connor, who would like to directly inhibit the source of free radicals rather than scavenge for them once they are formed. An estimated 1-in-50 patients in the United States develop treatment-resistant hypertension, which increases the risk of heart attack, stroke and other complications, according to studies published in the American Heart Association journal Circulation.

HV1 was discovered in 2006 in immune cells where is helps ensure the proper activity of the enzyme NADPH oxidase, which actually produces free radicals. It's now been found in a variety of cell types, and scientists are exploring its potential role in maladies such as ischemic stroke and cancer. O'Connor notes that his HIV mutant rats do not appear to have a compromised immune system.

O'Connor joined the MCG faculty in 2011.


'/>"/>

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University
Source:Eurekalert  

Related biology news :

1. Common genetic mutation increases sodium retention, blood pressure
2. Southwest regional warming likely cause of pinyon pine cone decline, says CU study
3. Study: Viral reactivation a likely link between stress and heart disease
4. Scientists find gene interactions that make cocaine abuse death 8 times more likely
5. Men more likely to commit research misconduct than female counterparts
6. Host cholesterol secretion likely to influence gut microbiota
7. Climate warming unlikely to cause near-term extinction of Amazon trees, but threats remain
8. Warming climate unlikely to cause extinction of ancient Amazon trees, study finds
9. Researchers identify proteins that indicate which kidney tumors are most likely to spread
10. Rhode Island Hospital: Adult entertainment workers likely to benefit from health care intervention
11. International team discovers likely basis of birth defect causing premature skull closure in infants
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sodium transporter appears likely target for treating salt-sensitive hypertension
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
(Date:2/10/2017)... -- Research and Markets has announced the ... Scientific and Commercial Aspects" to their offering. ... Biomarkers play ... therapy for selection of treatment as well for monitoring the ... disease in modern medicine. Biochip/microarray technologies and next generation sequencing ...
(Date:2/8/2017)... NEW YORK , Feb. 8, 2017 /PRNewswire/ ... an individual,s voice to match it against a ... voice such as pitch, cadence, and tone are ... systems require minimal hardware installation, as most PCs ... remotely for different transactions. Voice recognition biometrics are ...
Breaking Biology News(10 mins):
(Date:2/18/2017)... ... February 17, 2017 , ... A ... in Hong Kong. , Nerium International is proud to introduce its Age-Defying Night ... Cream, NeriumAD™ Formula to consumers across Hong Kong. The luxury skincare products contain ...
(Date:2/17/2017)... 2017 According to a ... (Consumables, Service), Type (Safety, Efficacy, Validation), Disease Indication ... and Development, Disease-Risk) - Global Forecast to 2021" ... reach USD 53.34 Billion by 2021 from USD ... of 13.8% during the forecast period (2016-2021). ...
(Date:2/17/2017)... 2017  If only one in every hundred ... resistance to chemotherapy, thousands of cancer cells would ... on finding these mutations in ever-smaller subpopulations of ... DNA in blood — to guide treatment decisions ... Unfortunately, however, detecting these genetic anomalies may be ...
(Date:2/17/2017)...  Protagonist Therapeutics, Inc. (NASDAQ: PTGX) today presented ... drug candidates, PTG-100 and PTG-200, at the 12 ... Colitis Organization (ECCO).  The ECCO congress is being ... from February 15 – 18, 2017. ... drug candidates PTG-100 and PTG-200. PTG-100, a potential ...
Breaking Biology Technology: